Bellevue Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $24.9M | Buy |
206,591
+114,474
| +124% | +$13.2M | 0.59% | 45 |
|
|
2025
Q4 | $9.7M | Buy |
92,117
+57,378
| +165% | +$5.39M | 0.18% | 63 |
|
|
2025
Q3 | $2.92M | Buy |
34,739
+6,500
| +23% | +$535K | 0.06% | 88 |
|
|
2025
Q2 | $2.24M | Sell |
28,239
-203,132
| -88% | -$16.1M | 0.05% | 93 |
|
|
2025
Q1 | $20.8M | Sell |
231,371
-32,855
| -12% | -$3.07M | 0.47% | 49 |
|
|
2024
Q4 | $26.3M | Buy |
264,226
+221,993
| +526% | +$22.9M | 0.51% | 51 |
|
|
2024
Q3 | $4.8M | Sell |
42,233
-32,476
| -43% | -$3.86M | 0.08% | 98 |
|
|
2024
Q2 | $9.25M | Sell |
74,709
-236,142
| -76% | -$30.4M | 0.15% | 90 |
|
|
2024
Q1 | $41M | Buy |
310,851
+20,645
| +7% | +$2.54M | 0.63% | 52 |
|
|
2023
Q4 | $31.6M | Sell |
290,206
-1,690
| -0.6% | -$175K | 0.48% | 62 |
|
|
2023
Q3 | $30.1M | Sell |
291,896
-14,798
| -5% | -$1.59M | 0.48% | 61 |
|
|
2023
Q2 | $35.4M | Buy |
306,694
+299,619
| +4,235% | +$34M | 0.5% | 62 |
|
|
2023
Q1 | $753K | Buy |
7,075
+324
| +5% | +$35K | 0.01% | 134 |
|
|
2022
Q4 | $749K | Buy |
6,751
+1,907
| +39% | +$195K | 0.01% | 143 |
|
|
2022
Q3 | $417K | Buy |
4,844
+3,880
| +402% | +$346K | 0.01% | 151 |
|
|
2022
Q2 | $88K | Buy |
+964
| New | +$85.5K | ﹤0.01% | 165 |
|
|
2020
Q1 | – | Sell |
-31,440
| Closed | -$2.73M | – | 224 |
|
|
2019
Q4 | $2.73M | Buy |
+31,440
| New | +$2.58M | 0.04% | 121 |
|
|
2019
Q2 | – | Sell |
-15,720
| Closed | -$1.25M | – | 210 |
|
|
2019
Q1 | $1.25M | Hold |
15,720
| – | – | 0.07% | 120 |
|
|
2018
Q4 | $1.15M | Buy |
15,720
+2,620
| +20% | +$185K | 0.08% | 113 |
|
|
2018
Q3 | $887K | Hold |
13,100
| – | – | 0.06% | 128 |
|
|
2018
Q2 | $759K | Hold |
13,100
| – | – | 0.06% | 126 |
|
|
2018
Q1 | $681K | Sell |
13,100
-15,720
| -55% | -$849K | 0.07% | 115 |
|
|
2017
Q4 | $1.55M | Hold |
28,820
| – | – | 0.16% | 93 |
|
|
2017
Q3 | $1.76M | Hold |
28,820
| – | – | 0.18% | 85 |
|
|
2017
Q2 | $1.76M | Hold |
28,820
| – | – | 0.21% | 83 |
|
|
2017
Q1 | $1.75M | Hold |
28,820
| – | – | 0.23% | 83 |
|
|
2016
Q4 | $1.62M | Sell |
28,820
-20,436
| -41% | -$1.2M | 0.33% | 73 |
|
|
2016
Q3 | $2.93M | Hold |
49,256
| – | – | 0.53% | 56 |
|
|
2016
Q2 | $2.71M | Sell |
49,256
-13,624
| -22% | -$725K | 0.51% | 61 |
|
|
2016
Q1 | $3.17M | Buy |
+62,880
| New | +$3.08M | 0.58% | 57 |
|
Other funds holding MRK
VCM
VPM
Bellevue Group's MRK Position: Q1 2026 in Review
Bellevue Group increased its Merck (MRK) stake by 124% in Q1 2026, buying an estimated $13.2M and bringing the position to 206,591 shares worth $24.9M. The position accounts for 0.59% of the portfolio, ranked #45.
Bellevue Group first reported a position in MRK in Q1 2016 and has held it in 30 quarters since. The position peaked at $41M in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Bellevue Group held 206,591 shares of Merck worth $24.9M as of Q1 2026.
- Bellevue Group bought 114,474 Merck shares in Q1 2026, an estimated $13.2M.
- Merck made up 0.59% of Bellevue Group's portfolio in Q1 2026, its #45 holding.
- Bellevue Group first reported a position in Merck in Q1 2016 and has held it in 30 quarters since.
- Bellevue Group's Merck position peaked at $41M in Q1 2024.
- 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Bellevue Group's 13F filing for Q1 2026, filed 15 May 2026.